Clinical Trial

Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Study acronym: ALSDPEG
Recruiting
View on ClinicalTrials.gov →
Summary
In Amyotrophic Lateral Sclerosis, dysphagia has a high incidence. With deterioration of swallowing function, percutaneous endoscopic gastrostomy (PEG) tube is recommended to ensure sufficient and safe oral intake. Dysphagia and PEG placement alter quality of life (QoL). However, QoL and attitudes toward PEG remain largely unexplored. The purpose of this study is to monitor the swallowing function in relationship to QoL and attitudes toward PEG tube insertion and feeding.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-04-14; most recent amendment 2026-06-11.
Status change: Not Yet Recruiting → Recruiting 2023-09-18
Trial Details
NCT Number NCT05336760
Lead Sponsor University Rehabilitation Institute, Republic of Slovenia
Collaborators: University Medical Centre Ljubljana
Conditions Amyotrophic Lateral Sclerosis
Enrollment 60 participants
Start Date 2023-01-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-15